Jump to navigation
CONFUSION surrounds new regulations for prescribing Di-Gesic and Doloxene (dextropropoxyphene, DPP), despite the latest ruling by the Administrative Appeals Tribunal (AAT).
If you have an account select Login. If you are new to Medical Observer select Join.
Neil Bramwell is a regular feature writer and contributor for MO.
More articles by this author >
Cirrus Media is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.